GlaxoSmithKline Accused Of Burying Negative Paxil Studies & Keeping Info From FDA

Get Legal Help Today

secured lock Secured with SHA-256 Encryption

Jeffrey Johnson is a legal writer with a focus on personal injury. He has worked on personal injury and sovereign immunity litigation in addition to experience in family, estate, and criminal law. He earned a J.D. from the University of Baltimore and has worked in legal offices and non-profits in Maryland, Texas, and North Carolina. He has also earned an MFA in screenwriting from Chapman Univer...

Full Bio →

Written by Jeffrey Johnson
Insurance Lawyer Jeffrey Johnson

UPDATED: Jun 29, 2022

Advertiser Disclosure

It’s all about you. We want to help you make the right legal decisions.

We strive to help you make confident insurance and legal decisions. Finding trusted and reliable insurance quotes and legal advice should be easy. This doesn’t influence our content. Our opinions are our own.

Editorial Guidelines: We are a free online resource for anyone interested in learning more about legal topics and insurance. Our goal is to be an objective, third-party resource for everything legal and insurance related. We update our site regularly, and all content is reviewed by experts.

GlaxoSmithKline (GSK) executives are being accused of burying negative studies on the company’s antidepressant drug, Paxil, and its link to birth defects – from consumers and the U.S. Food and Drug Adminstration (FDA). The allegations are likely to have a very damaging effect on the pharmaceutical giant as Paxil litigation begins in the United States.

“If neg, results can bury”

That statement was written by GSK executive Bonnie Rosello in 1997 and referenced what the company should do if it was forced to conduct studies on animals regarding Paxil. Hiding information and failing to warn consumers about the dangers of Paxil are key points in all of the Paxil cases now being litigated.

The first trial, now ongoing in Philadelphia, alleges that GSK knew that Paxil caused birth defects as far back as 1980, but hid those risks from consumers and the FDA to increase sales. Plaintiffs in the first case are the parents of Lyam Kilker, a three year old boy who suffered life threatening heart defects and had to have multiple surgeries because his mother took Paxil during her pregnancy.

Another trial currently ongoing in Boston, involves William Seale, a one year old boy who died in 2004 after his mother took Paxil while she was pregnant. Unfortunately, there are approximately 600 more lawsuits pending which link Paxil to a variety of birth defects and suicides.

Birth defects & suicide

Paxil has been linked to countless birth defects such as cardiac (heart), pulmonary (lung), neural-tube defects (brain and spinal cord), craniosynostosis (abnormally shaped skull), infant omphalocele (abdominal wall defects), club foot (one or both feet turn downward and inward), anal atresia (complete or partial closure of the anus) and suicide or homicidal thoughts. In fact, the company settled a lawsuit with the New York Attorney General’s Office for $2.5 million over allegations that GSK suppressed research showing that Paxil may increase the risk of suicide in young people.

If you’ve been injured by Paxil, contact an experienced drug litigation attorney for a free case review. You may be entitled to compensation for your injuries.

Get Legal Help Today

Find the right lawyer for your legal issue.

secured lock Secured with SHA-256 Encryption